DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

Trexquant Investment LP's Holding History (CIK: 0001633445)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 209,609 Value ($000) $3,461 Avg Close $16.88 Range $13.75 - $20.61
Q3 2025
Shares 430,566 Value ($000) $6,252 Avg Close $14.37 Range $12.58 - $16.20
Q2 2025
Shares 109,242 Value ($000) $1,528 Avg Close $14.07 Range $10.57 - $16.97
Q1 2025
Shares 113,224 Value ($000) $1,539 Avg Close $19.16 Range $13.30 - $24.34
Q4 2024
Shares 60,656 Value ($000) $1,236 Avg Close $25.60 Range $19.93 - $33.33
Q3 2024
Shares 24,534 Value ($000) $715 Avg Close $24.79 Range $19.74 - $32.13
Q3 2023
Shares 42,349 Value ($000) $874 Avg Close $25.37 Range $20.52 - $30.79
Q2 2023
Shares 66,935 Value ($000) $1,975 Avg Close $28.12 Range $22.72 - $33.31
Q1 2023
Shares 80,524 Value ($000) $1,855 Avg Close $27.52 Range $21.74 - $32.81
Q4 2022
Shares 22,855 Value ($000) $636 Avg Close $29.75 Range $25.96 - $34.78
Q3 2022
Shares 25,629 Value ($000) $787 Avg Close $32.51 Range $25.88 - $39.43
Q1 2021
Shares 16,192 Value ($000) $925 Avg Close $66.94 Range $52.23 - $84.25
Q3 2020
Shares 40,025 Value ($000) $1,434 Avg Close $30.12 Range $22.36 - $39.22
Q2 2018
Shares 10,151 Value ($000) $155 Avg Close $18.84 Range $15.19 - $22.99